Atypical teratoid/rhabdoid tumor (AT/RT)

Also called Atypical teratoid/rhabdoid tumor of the central nervous system

Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, aggressive tumor of the brain or spinal cord, often associated with loss of SMARCB1 function or, less commonly, SMARCA4. Tissue and molecular testing guide diagnosis and may prompt genetic counseling.

Other names and abbreviations

AT/RT, ATRT, CNS AT/RT, atypical teratoid rhabdoid tumor, malignant rhabdoid brain tumor, CNS atypical teratoid/rhabdoid tumour, malignant rhabdoid tumour of the CNS

In short

  • AT/RT is a rare, aggressive tumor of the brain or spinal cord that mainly affects very young children, though older children and adults can get it too.
  • Treatment usually combines surgery, intensive chemotherapy and radiation, adjusted for the patient's age, where the tumor sits and how far it reaches.
  • Some treatment plans add high-dose chemotherapy followed by a return of the patient's own saved stem cells, so this step does not need a marrow donor.
Jump to a section

Underlined words open a short explanation. See all terms

Where transplant fits

When rescue is used, it normally returns the patient’s own collected cells after intensive chemotherapy. It is one component of selected multimodal regimens, not a treatment requiring an unrelated donor.

Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.

Key facts

Who it affects
AT/RT mainly affects very young children, although older children and adults can be affected.
Usual treatment
Treatment combines approaches such as surgery, intensive chemotherapy and radiation, adapted to the child’s age, tumor location, extent and protocol. Some regimens include high-dose chemotherapy with autologous stem cell rescue.
Cells used in a transplant
The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
Where a donor fits
Limited transplant role

Support for patients and families

These independent organizations offer information and support. JBF is not affiliated with them.

Questions to bring to your care team

  • What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
  • What is the goal of each treatment you are suggesting?
  • What would make a transplant worth considering later on?
  • Are there clinical trials that might fit?
  • Where can our family find support during treatment?

Supporting someone with a diagnosis

Sources and further reading

  1. Childhood Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ)
    NCI, Accessed 2026-09-05
  2. Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
    EBMT / Bone Marrow Transplantation, Accessed 2026-09-05
  3. Stem Cell and Bone Marrow Transplants for Cancer
    NCI, Accessed 2026-09-05

Other patients are waiting for a match.

Most people with atypical teratoid/rhabdoid tumor (AT/RT) are treated without a registry donor. Many people with other blood cancers and blood disorders need a donor who is a stranger.

Join the registry

JBF points you to the official registry that serves your country. It explains who can join and what donation involves.

Help a family run a drive

If someone you love needs a donor, a registration drive can add many potential donors at once, for them and for others.

Support this work

Gifts to the Jada Bascom Foundation support donor-awareness education like this guide, community outreach, drive planning and referrals to official registries.

Donate to JBF

We respect your privacy. Unsubscribe anytime.

Keep learning